SCHEMBL19630169

SCHEMBL19630169

CC/C(=C/NC1CC1)N=N

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ADH1B P00325 1/20 0.30
ADH1A P07327 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19630322 0.72
SCHEMBL22572483 0.72
SCHEMBL20908175 0.68
SCHEMBL19158667 0.64
SCHEMBL23620711 0.64 ADH1B (0.34) ADH1BADH1A
SCHEMBL22667020 0.64 ADH1B (0.40) ADH1BADH1A
SCHEMBL1678408 0.63
SCHEMBL31186562 0.61 ADH1B (0.41) ADH1BADH1A
SCHEMBL15047184 0.61
SCHEMBL25073967 0.60 EPHX1 (0.38) ADH1BADH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017200857-A1 METHODS FOR USING TRIAZOLO-PYRAZINYL SOLUBLE GUANYLATE CYCLASE ACTIVATORS IN FIBROTIC DISORDERS MERCK SHARP & DOHME CORP. (US) 2017-11-23 WO disclosed